Company Filing History:
Years Active: 2025
Title: Innovations of Jung Soo Nam in Pharmaceutical Chemistry
Introduction
Jung Soo Nam is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. His work focuses on innovative solutions for treating diseases linked to abnormal enzyme activity.
Latest Patents
Jung Soo Nam holds a patent for "Imidazopyridine derivative compounds and use of same." This patent describes a compound selected from a chemical formula that exhibits lysine-specific demethylase-1 (LSD1) inhibitory activity. The compound is effective in preventing or treating diseases caused by the abnormal activation of LSD1. Additionally, the patent discloses a composition containing the compound as an active ingredient, highlighting its potential therapeutic applications.
Career Highlights
Jung Soo Nam is currently associated with Hanmi Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His role involves research and development of innovative drug compounds that can address unmet medical needs. His expertise in medicinal chemistry has positioned him as a valuable asset in the field.
Collaborations
Jung Soo Nam has collaborated with notable colleagues, including In Hwan Bae and Won Jeoung Kim. These collaborations have fostered a productive research environment, leading to advancements in their shared field of study.
Conclusion
Jung Soo Nam's contributions to pharmaceutical chemistry, particularly through his patent on Imidazopyridine derivative compounds, demonstrate his commitment to innovation in medicine. His work continues to pave the way for new treatments that can significantly impact patient care.